A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers
Clinical trial NCT01732198 · UNKNOWN
Trial details
- NCT number
- NCT01732198
- Sponsor
- Nuron Biotech Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.